空間體學市場規模、佔有率、成長分析，按技術、按產品類型、按工作流程、按樣本類型、按最終用途、按地區 - 行業預測，2025 年至 2032 年

2023 年全球空間體學市場規模價值為 3,650 億美元，預計將從 2024 年的 4029.6 億美元成長到 2032 年的 8,892.3 億美元，預測期內（2025-2032 年）的複合年成長率為 10.4%。

由於遺傳疾病盛行率的不斷上升、定序技術的進步以及創新研究投入的不斷增加，空間體學市場正在經歷顯著的成長。這種變革性方法將重點從基因定序轉移到分析細胞類型和生物標記的空間關係和相互作用。該領域的主要企業提供量化約 1,800 個 RNA 目標的解決方案，有效地將分子分析與組織的空間資料結合。這種空間基因組資訊對於開發診斷生物標記以輔助疾病識別和管理至關重要。因此，空間體學技術對於理解複雜的生物機制（包括組織組織和細胞調節）以及最終改善治療策略和臨床結果至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

空間組體學市場規模（依技術分類）

• 市場概況
• 空間轉錄組學
• 空間基因體學
• 空間蛋白質體學

空間組體學市場規模（依產品分類）

• 市場概況
• 裝置
  • 按模式
  • 自動化
  • 半自動
  • 手動的
  • 按類型
  • 定序平台
  • 全球健康
  • 顯微鏡
  • 流式細胞技術
  • 質譜分析
  • 其他
• 耗材
• 軟體
  • 生物資訊學工具
  • 影像工具
  • 儲存和管理資料庫

空間組體學市場規模（按工作流程）

• 市場概況
• 樣品製備
• 儀器分析
• 資料分析

空間組體學市場規模（依樣本類型）

• 市場概況
• FFPE
• 新鮮冷凍

空間體學市場規模（依最終用途分類）

• 市場概況
• 學術和轉化研究機構
• 製藥和生物技術公司

空間組體學市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• 10x Genomics（US）
• Illumina（US）
• Fluidigm Corporation（US）
• Akoya Biosciences（formerly PerkinElmer）（US）
• S2 Genomics, Inc.（US）
• RareCyte, Inc.（US）
• ZEISS Group（Germany）
• Miltenyi Biotec（Germany）
• Bio-Techne Corporation（US）
• Visiopharm（Denmark）
• Indica Labs, Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Oxford Nanopore Technologies（UK）
• Takara Bio Inc.（Japan）

結論和建議

Global Spatial Omics Market size was valued at USD 365.0 billion in 2023 and is poised to grow from USD 402.96 billion in 2024 to USD 889.23 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

The spatial omics market is experiencing significant growth, driven by the increasing prevalence of genetic disorders, advancements in sequencing technologies, and heightened investment in innovative research. This transformative approach shifts focus from decoding gene sequences to analyzing the spatial positioning and interactions of cell types and biomarkers. Leading companies in the field are delivering solutions that quantify approximately 1,800 RNA targets, effectively merging molecular analysis with spatial data from tissues. This spatial genomic information is proving essential for developing diagnostic biomarkers that aid in disease identification and management. As such, spatial omics technology is crucial for understanding complex biological mechanisms, including tissue organization and cellular regulation, ultimately enhancing therapeutic strategies and clinical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segmental Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The Global Spatial Omics market is poised for significant growth, driven primarily by the increasing prevalence of genetic disorders that tend to be hereditary. As uncertainties surrounding health conditions rise, there is a growing desire among individuals to understand and detect these disorders through advanced omics technologies. This demand underscores the importance of spatial omics tools, which facilitate the identification and analysis of genetic anomalies within various biological samples. Consequently, the need for these innovative diagnostics and research solutions is propelling the expansion of the spatial omics market, making it a critical sector in addressing genetic health challenges.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces significant restraints that may impede its growth prospects. One major challenge is the shortage of skilled professionals with expertise in this emerging research domain, which is expected to limit advancements and further developments. Since Spatial Omics is still a relatively novel field, there is a lack of widespread acceptance and understanding, leading to cautious adoption among researchers and institutions. This limited recognition can stifle innovation and investment, ultimately hindering the overall expansion of the market during the forecast period. Addressing these issues will be crucial to unlocking the full potential of Spatial Omics.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is currently witnessing a significant uptick as the demand for advanced diagnostic tools grows, particularly in oncology. The innovative spatial omics techniques, which effectively elucidate the complex mechanisms governing cell interactions at tumor boundaries, are gaining traction due to their potential to enhance early malignancy detection. This trend is fueled by increasing investments in research and development, coupled with rising prevalence of cancers worldwide. Furthermore, the integration of spatial omics with existing genomic and transcriptomic technologies promises breakthroughs in personalized medicine, paving the way for a robust market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
  • By Mode
  • Automated
  • Semi-automated
  • Manual
  • By Type
  • Sequencing Platforms
  • IHC
  • Microscopy
  • Flow Cytometry
  • Mass Spectrometry
  • Others
• Consumables
• Software
  • Bioinformatics Tools
  • Imaging Tools
  • Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
• Instrumental Analysis
• Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• FFPE
• Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2025-2032)

• North America (Technology, Product, Workflow, Sample Type, End-use)
  • US
  • Canada
• Europe (Technology, Product, Workflow, Sample Type, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Workflow, Sample Type, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 10x Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences (formerly PerkinElmer) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S2 Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RareCyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations